Photoacoustic Imaging (PAI) of Suspicious Breast Cancers - A Clinical Feasibility Study

Trial ID or NCT#

NCT01780532

Status

not recruiting iconNOT RECRUITING

Purpose

After locating the suspicious lesion/mass with standard of care mammography and/or ultrasound, a photoacoustic scan will be performed in the breast where the lesion is located. After the PA scan a biopsy will be performed, if clinically indicated (based on the mammogram and ultrasound only).

Official Title

Pilot Photoacoustic Imaging (PAI) of Suspicious Breast Cancers - A Clinical Feasibility Study

Eligibility Criteria

Ages Eligible for Study: 18 Years to 80 Years
Sexes Eligible for Study: Female
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. - Patients must have a breast lesion/mass found at physical examination, mammography or ultrasound (US), that has not been surgically resected - Patients may have any of the following characteristics: - Taking hormones (e.g., contraceptives, hormone replacement therapy, post-cancer Tamoxifen) - Breast implants - Previous breast biopsy - Previous breast surgery - Previous breast cancer - High risk of breast cancer (e.g., breast cancer susceptibility gene (BRCA) mutations, other gynecologic cancer) - Ability to understand and the willingness to sign a written informed consent document
Exclusion Criteria:
  1. - Patients who have had primary surgical excision of the suspicious finding - Pregnant or lactating women
View All Criteria
Show Less

Investigator(s)

Sanjiv Sam Gambhir, MD, PhD

View on ClinicalTrials.gov